We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Drugs for Macular Degeneration, Price Discrimination, and Medicare's Responsibility Not to Overpay.
- Authors
Silver, Jonathan
- Abstract
The author comments on the release of information on payments made by the Medicare program to individual physicians on 2012, which showed that ophthalmologists were among the highest number of physicians who received payments exceeding 1 million U.S. dollars. Topics covered include reimbursement for treatment of age-related macular degeneration (AMD), price discrimination in AMD drugs, and the responsibility of Medicare not to overpay.
- Subjects
UNITED States; HEALTH insurance reimbursement; MEDICARE; OPHTHALMOLOGISTS; RETINAL degeneration treatment; PRICE discrimination; DRUGS; OVERPAYMENT
- Publication
JAMA: Journal of the American Medical Association, 2014, Vol 312, Issue 1, p23
- ISSN
0098-7484
- Publication type
Opinion
- DOI
10.1001/jama.2014.6672